SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-22-009191
Filing Date
2022-04-01
Accepted
2022-04-01 16:02:34
Documents
2
Period of Report
2022-03-23

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2279
2 POA exhibit24-1.htm EX-24.1 3800
  Complete submission text file 0001062993-22-009191.txt   7607
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIODELIVERY SCIENCES INTERNATIONAL, INC. 4131 PARKLAKE AVE SUITE 225 RALEIGH NC 27612
Business Address
Smith Thomas B (Reporting) CIK: 0001748462 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37372 | Film No.: 22798145